Extracorporeal Membrane Oxygenation for Respiratory Failure

This review focuses on the use of veno-venous extracorporeal membrane oxygenation for respiratory failure across all blood flow ranges. Starting with a short overview of historical development, aspects of the physiology of gas exchange (i.e., oxygenation and decarboxylation) during extracorporeal circulation are discussed. The mechanisms of phenomena such as recirculation and shunt playing an important role in daily clinical practice are explained. Treatment of refractory and symptomatic hypoxemic respiratory failure (e.g., acute respiratory distress syndrome [ARDS]) currently represents the main indication for high-flow veno-venous-extracorporeal membrane oxygenation. On the other hand, lower-flow extracorporeal carbon dioxide removal might potentially help to avoid or attenuate ventilator-induced lung injury by allowing reduction of the energy load (i.e., driving pressure, mechanical power) transmitted to the lungs during mechanical ventilation or spontaneous ventilation. In the latter context, extracorporeal carbon dioxide removal plays an emerging role in the treatment of chronic obstructive pulmonary disease patients during acute exacerbations. Both applications of extracorporeal lung support raise important ethical considerations, such as likelihood of ultimate futility and end-of-life decision-making. The review concludes with a brief overview of potential technical developments and persistent challenges. This review presents an overview of selected aspects of extracorporeal membrane oxygenation use in respiratory failure, including historical and technical development, relevant principles of gas exchange, clinical applications and indications, ethical considerations, and potential improvements for its optimal implementation.

[1]  G. Iotti,et al.  An experimental model of veno-venous arterial extracorporeal membrane oxygenation , 2020, The International journal of artificial organs.

[2]  D. Brodie,et al.  Low-flow assessment of current ECMO/ECCO2R rotary blood pumps and the potential effect on hemocompatibility , 2019, Critical Care.

[3]  M. Quintel,et al.  Breathing and Ventilation during Extracorporeal Membrane Oxygenation: How to Find the Balance between Rest and Load , 2019, American journal of respiratory and critical care medicine.

[4]  D. Brodie,et al.  Mechanical Ventilation Management during ECMO for ARDS: An International Multicenter Prospective Cohort. , 2019, American journal of respiratory and critical care medicine.

[5]  V. Ranieri,et al.  Alveolar recruitment in acute respiratory distress syndrome: should we open the lung (no matter what) or may accept (part of) the lung closed? , 2019, Intensive Care Medicine.

[6]  G. Grasselli,et al.  Hemoglobin trigger and approach to red blood cell transfusions during veno-venous extracorporeal membrane oxygenation: the international TRAIN-ECMO survey , 2019, Perfusion.

[7]  G. Bugedo,et al.  Near‐Apneic Ventilation Decreases Lung Injury and Fibroproliferation in an Acute Respiratory Distress Syndrome Model with Extracorporeal Membrane Oxygenation , 2019, American journal of respiratory and critical care medicine.

[8]  V. Ranieri,et al.  Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study , 2019, Intensive Care Medicine.

[9]  Ryan P. Barbaro,et al.  The ELSO Maastricht Treaty for ECLS Nomenclature: abbreviations for cannulation configuration in extracorporeal life support - a position paper of the Extracorporeal Life Support Organization , 2019, Critical Care.

[10]  F. Rapetti,et al.  Extracorporeal CO2 Removal: The Minimally Invasive Approach, Theory, and Practice* , 2019, Critical care medicine.

[11]  D. Angus,et al.  Time for Clinicians to Embrace Their Inner Bayesian?: Reanalysis of Results of a Clinical Trial of Extracorporeal Membrane Oxygenation. , 2018, JAMA.

[12]  Y. Toyoda,et al.  Artificial Lungs for Lung Failure: JACC Technology Corner. , 2018, Journal of the American College of Cardiology.

[13]  P. Wearden,et al.  Paracorporeal Lung Devices: Thinking Outside the Box , 2018, Front. Pediatr..

[14]  Hakeem O. Yusuff,et al.  Awake extracorporeal membrane oxygenation patients expanding the horizons. , 2018, Journal of thoracic disease.

[15]  O. Moerer,et al.  Extracorporeal Gas Exchange. , 2018, Critical care clinics.

[16]  C. Chaignat,et al.  Daily use of extracorporeal CO2 removal in a critical care unit: indications and results , 2018, Journal of Intensive Care.

[17]  J. Drazen,et al.  Learning from a Trial Stopped by a Data and Safety Monitoring Board. , 2018, The New England journal of medicine.

[18]  D. Brodie,et al.  Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome , 2018, The New England journal of medicine.

[19]  A. Zanella,et al.  Effects of sodium citrate, citric acid and lactic acid on human blood coagulation , 2018, Perfusion.

[20]  S. Jaber,et al.  Feasibility and safety of low-flow extracorporeal CO2 removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS , 2018, Critical Care.

[21]  P. Pelosi,et al.  Close down the lungs and keep them resting to minimize ventilator-induced lung injury , 2018, Critical Care.

[22]  M. Di Nardo,et al.  Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics. , 2018, Journal of thoracic disease.

[23]  J. Roberts,et al.  Optimising drug dosing in patients receiving extracorporeal membrane oxygenation. , 2018, Journal of thoracic disease.

[24]  M. Maggiorini,et al.  Patient selection for extracorporeal CO2 removal: a task as challenging as for ECMO therapy. , 2018, Minerva anestesiologica.

[25]  G. Grasselli,et al.  Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study , 2018, Annals of Intensive Care.

[26]  M. Ranieri,et al.  Intermittent extracorporeal CO2 removal in chronic obstructive pulmonary disease patients: a fiction or an option , 2017, Current opinion in critical care.

[27]  Claude,et al.  Extracorporeal Membrane Oxygenation ( ECMO ) for Newborn Persistent Fetal Circulation , 2017 .

[28]  D. Brodie,et al.  Treatment limitations in the era of ECMO. , 2017, The Lancet. Respiratory medicine.

[29]  L. Camporota,et al.  The evolving role and practical application of extracorporeal carbon dioxide removal in critical care. , 2017, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[30]  D. Brodie,et al.  Extracorporeal Membrane Oxygenation for Adult Respiratory Failure: 2017 Update , 2017, Chest.

[31]  K. Cook,et al.  Fourteen Day In Vivo Testing of a Compliant Thoracic Artificial Lung , 2017, ASAIO journal.

[32]  S. Weber-Carstens,et al.  Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support , 2017, Annals of Intensive Care.

[33]  D. Brodie,et al.  Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosis , 2017, Intensive Care Medicine Experimental.

[34]  S. Keenan,et al.  Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure , 2017, European Respiratory Journal.

[35]  D. Brodie,et al.  Awake Extracorporeal Membrane Oxygenation as Bridge to Lung Transplantation: A 9-Year Experience. , 2017, The Annals of thoracic surgery.

[36]  F. Rapetti,et al.  The future of mechanical ventilation: lessons from the present and the past , 2017, Critical Care.

[37]  J. Fraser,et al.  Bivalirudin for Alternative Anticoagulation in Extracorporeal Membrane Oxygenation: A Systematic Review , 2017, Journal of intensive care medicine.

[38]  J. Kellum,et al.  Extracorporeal CO2 removal by hemodialysis: in vitro model and feasibility , 2017, Intensive Care Medicine Experimental.

[39]  N. Bottino,et al.  Spontaneous Breathing during Extracorporeal Membrane Oxygenation in Acute Respiratory Failure , 2017, Anesthesiology.

[40]  D. Brodie,et al.  Understanding ethical decisions for patients on extracorporeal life support , 2017, Intensive Care Medicine.

[41]  D. Brodie,et al.  Medicating patients during extracorporeal membrane oxygenation: the evidence is building , 2017, Critical Care.

[42]  A. Haverich,et al.  Endothelialization and characterization of titanium dioxide-coated gas-exchange membranes for application in the bioartificial lung. , 2017, Acta biomaterialia.

[43]  Ahmad Khairi Abdul Wahab,et al.  Extracorporeal carbon dioxide removal (ECCO2R) in respiratory deficiency and current investigations on its improvement: a review , 2017, Journal of Artificial Organs.

[44]  Jason A. Roberts,et al.  Right Dose, Right Now: Customized Drug Dosing in the Critically Ill , 2017, Critical care medicine.

[45]  F. Machado.  All in a Day's Work - Equity vs. Equality at a Public ICU in Brazil. , 2016, The New England journal of medicine.

[46]  K. Palmér,et al.  Cannula Design and Recirculation During Venovenous Extracorporeal Membrane Oxygenation , 2016, ASAIO journal.

[47]  J. McCannon,et al.  Ethics Committee Consultation and Extracorporeal Membrane Oxygenation. , 2016, Annals of the American Thoracic Society.

[48]  P. Wearden,et al.  ECMO Biocompatibility: Surface Coatings, Anticoagulation, and Coagulation Monitoring , 2016 .

[49]  L. Gattinoni,et al.  Ventilator-related causes of lung injury: the mechanical power , 2016, Intensive Care Medicine.

[50]  Stefano Ferrero,et al.  Role of Strain Rate in the Pathogenesis of Ventilator-Induced Lung Edema* , 2016, Critical care medicine.

[51]  P. Tapia,et al.  Liquid extracorporeal carbon dioxide removal: use of THAM (tris-hydroxymethyl aminomethane) coupled to hemofiltration to control hypercapnic acidosis in a porcine model of protective mechanical ventilation. , 2016, American journal of translational research.

[52]  R. Bartlett.  Clinical Research in Acute Fatal Illness , 2016, Journal of intensive care medicine.

[53]  T. Staudinger,et al.  The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case–control study , 2016, Intensive Care Medicine.

[54]  J. Seume,et al.  Developing a biohybrid lung - sufficient endothelialization of poly-4-methly-1-pentene gas exchange hollow-fiber membranes. , 2016, Journal of the mechanical behavior of biomedical materials.

[55]  A. Pesenti,et al.  “Awake” extracorporeal membrane oxygenation (ECMO): pathophysiology, technical considerations, and clinical pioneering , 2016, Critical Care.

[56]  S. Weber-Carstens,et al.  The German ECMO inflation: when things other than health and care begin to rule medicine , 2016, Intensive Care Medicine.

[57]  Massimo Cressoni,et al.  Mechanical Power and Development of Ventilator-induced Lung Injury , 2016, Anesthesiology.

[58]  J. Weitz.  Factor XI and factor XII as targets for new anticoagulants. , 2016, Thrombosis research.

[59]  A. Vuylsteke,et al.  Agreement between ACT and aPTT during extracorporeal membrane oxygenation shows intra- and inter-individual variation , 2016, Perfusion.

[60]  Shaoyi Jiang,et al.  Multimodal, Biomaterial‐Focused Anticoagulation via Superlow Fouling Zwitterionic Functional Groups Coupled with Anti‐Platelet Nitric Oxide Release , 2016 .

[61]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[62]  M. Ranieri,et al.  Feasibility and safety of low-flow extracorporeal carbon dioxide removal to facilitate ultra-protective ventilation in patients with moderate acute respiratory distress sindrome , 2016, Critical Care.

[63]  L. Camporota,et al.  Current Applications for the Use of Extracorporeal Carbon Dioxide Removal in Critically Ill Patients , 2016, BioMed research international.

[64]  D. Dreyfuss,et al.  Use of extracorporeal carbon dioxide removal (ECCO2R) in 239 intensive care units: results from a French national survey , 2016, Intensive Care Medicine.

[65]  Evi X. Stavrou,et al.  Factor XII: a novel target for safe prevention of thrombosis and inflammation , 2015, Journal of internal medicine.

[66]  L. Fasano,et al.  Effects of Extracorporeal CO2 Removal on Inspiratory Effort and Respiratory Pattern in Patients Who Fail Weaning from Mechanical Ventilation. , 2015, American journal of respiratory and critical care medicine.

[67]  R. Bartlett,et al.  Anticoagulation for Extracorporeal Life Support: Direct Thrombin Inhibitors and Heparin , 2015, ASAIO journal.

[68]  W. Federspiel,et al.  Acidic sweep gas with carbonic anhydrase coated hollow fiber membranes synergistically accelerates CO2 removal from blood. , 2015, Acta biomaterialia.

[69]  A. Zanella,et al.  Respiratory Electrodialysis. A Novel, Highly Efficient Extracorporeal CO2 Removal Technique. , 2015, American journal of respiratory and critical care medicine.

[70]  Jonathan W Haft,et al.  Roller and Centrifugal Pumps: A Retrospective Comparison of Bleeding Complications in Extracorporeal Membrane Oxygenation , 2015, ASAIO journal.

[71]  R. Thiagarajan,et al.  Ethical dilemmas with the use of ECMO as a bridge to transplantation. , 2015, The Lancet. Respiratory medicine.

[72]  L. Brochard,et al.  Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review , 2015, Intensive Care Medicine.

[73]  T. Welte,et al.  Veno-veno-arterial extracorporeal membrane oxygenation for respiratory failure with severe haemodynamic impairment: technique and early outcomes. , 2015, Interactive cardiovascular and thoracic surgery.

[74]  黄亚明,et al.  European Society of Intensive Care Medicine , 2005, Intensive Care Medicine.

[75]  Ryan P. Barbaro,et al.  Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. , 2015, American journal of respiratory and critical care medicine.

[76]  D. Brodie,et al.  Recirculation in Venovenous Extracorporeal Membrane Oxygenation , 2015, ASAIO journal.

[77]  S. Weber-Carstens,et al.  Extracorporeal life support, ethics, and questions at the bedside: how does the end of the pathway look? , 2015, Intensive Care Medicine.

[78]  P. Leprince,et al.  Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood , 2015, Critical Care.

[79]  M. Cove,et al.  Ethical dilemmas of adult ECMO: emerging conceptual challenges. , 2015, Journal of cardiothoracic and vascular anesthesia.

[80]  M. Bacchetta,et al.  ECMO as bridge to lung transplant. , 2015, Thoracic surgery clinics.

[81]  L. Fasano,et al.  Extracorporeal Co2 Removal in Hypercapnic Patients At Risk of Noninvasive Ventilation Failure: A Matched Cohort Study With Historical Control* , 2015, Critical care medicine.

[82]  P. Lindenauer,et al.  Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease. , 2014, JAMA internal medicine.

[83]  J. Vincent,et al.  Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study , 2014, Critical Care.

[84]  M. Gilbert,et al.  "Nobody is dead until warm and dead": prolonged resuscitation is warranted in arrested hypothermic victims also in remote areas--a retrospective study from northern Norway. , 2014, Resuscitation.

[85]  D. Brodie,et al.  Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. , 2014, American journal of respiratory and critical care medicine.

[86]  M. Fischer,et al.  Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study , 2014, Critical Care.

[87]  D. Brodie,et al.  Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults. , 2014, Chest.

[88]  A. Zanella,et al.  Regional Blood Acidification Enhances Extracorporeal Carbon Dioxide Removal: A 48-hour Animal Study , 2014, Anesthesiology.

[89]  Daniel Brodie,et al.  The appropriate use of increasingly sophisticated life-sustaining technology. , 2013, The virtual mentor : VM.

[90]  D. Brodie,et al.  Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. , 2013, Annals of the American Thoracic Society.

[91]  P. Leprince,et al.  The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome , 2013, Intensive Care Medicine.

[92]  N. Roewer,et al.  [Acute respiratory distress syndrome and septic cardiomyopathy : successful application of veno-venoarterial extracorporeal membrane oxygenation]. , 2013, Der Anaesthesist.

[93]  W. Federspiel,et al.  Carbonic anhydrase immobilized on hollow fiber membranes using glutaraldehyde activated chitosan for artificial lung applications , 2013, Journal of Materials Science: Materials in Medicine.

[94]  S. Jaber,et al.  Prone positioning in severe acute respiratory distress syndrome. , 2013, The New England journal of medicine.

[95]  Sylvie Chevret,et al.  Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. , 2013, American journal of respiratory and critical care medicine.

[96]  J. Fraser,et al.  Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern? , 2013, The Journal of antimicrobial chemotherapy.

[97]  F. Herth,et al.  A novel extracorporeal CO(2) removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. , 2013, Chest.

[98]  A. Vuylsteke,et al.  ECMO cannula review , 2013, Perfusion.

[99]  Arthur S Slutsky,et al.  Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS , 2013, Intensive Care Medicine.

[100]  D. Mannino,et al.  Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. , 2012, American journal of respiratory and critical care medicine.

[101]  J. Fraser,et al.  Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. , 2012, Journal of critical care.

[102]  Dionne A. Graham,et al.  Outcomes of neonates undergoing extracorporeal membrane oxygenation support using centrifugal versus roller blood pumps. , 2012, The Annals of thoracic surgery.

[103]  M. Bacchetta,et al.  Bridge to lung transplantation with extracorporeal membrane oxygenation support , 2012, Current opinion in organ transplantation.

[104]  N. Suttorp,et al.  Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation , 2012, Intensive Care Medicine.

[105]  W. Federspiel,et al.  Immobilized Carbonic Anhydrase on Hollow Fiber Membranes Accelerates CO(2) Removal from Blood. , 2012, Journal of membrane science.

[106]  Susanna Price,et al.  Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). , 2011, JAMA.

[107]  R. Charrel,et al.  Extracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: a prospective observational comparative study , 2010, Intensive Care Medicine.

[108]  Michael Bailey,et al.  Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. , 2009, JAMA.

[109]  Diana Elbourne,et al.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial , 2009, The Lancet.

[110]  V. Ranieri,et al.  Tidal Volume Lower than 6 ml/kg Enhances Lung Protection: Role of Extracorporeal Carbon Dioxide Removal , 2009, Anesthesiology.

[111]  M. Costanzi,et al.  Blood acidification enhances carbon dioxide removal of membrane lung: an experimental study , 2009, Intensive Care Medicine.

[112]  C. Schmid,et al.  First experience with a paracorporeal artificial lung in humans. , 2009, ASAIO journal.

[113]  P. Annaert,et al.  Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation. , 2009, The Journal of antimicrobial chemotherapy.

[114]  T. Welte,et al.  Bridge to Thoracic Organ Transplantation in Patients with Pulmonary Arterial Hypertension Using a Pumpless Lung Assist Device , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[115]  M. Grocott,et al.  Arterial blood gases and oxygen content in climbers on Mount Everest. , 2009, The New England journal of medicine.

[116]  B. Trabold,et al.  Bridge to lung transplantation through a pulmonary artery to left atrial oxygenator circuit. , 2008, The Annals of thoracic surgery.

[117]  Guillermo Bugedo,et al.  Anatomical and functional intrapulmonary shunt in acute respiratory distress syndrome* , 2008, Critical care medicine.

[118]  J. Riley,et al.  In vitro drug adsorption and plasma free hemoglobin levels associated with hollow fiber oxygenators in the extracorporeal life support (ECLS) circuit. , 2007, The journal of extra-corporeal technology.

[119]  J. Toomasian,et al.  Thirty-day in-parallel artificial lung testing in sheep. , 2007, The Annals of thoracic surgery.

[120]  J. Kaar,et al.  Towards improved artificial lungs through biocatalysis. , 2007, Biomaterials.

[121]  M. Singer,et al.  Mechanisms of sepsis-induced cardiac dysfunction , 2007, Critical care medicine.

[122]  J. Arnold,et al.  Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment , 2007, Intensive Care Medicine.

[123]  J. Zwischenberger,et al.  Artificial lung: progress and prototypes , 2006, Expert review of medical devices.

[124]  D. O’Donnell,et al.  COPD exacerbations · 3: Pathophysiology , 2006, Thorax.

[125]  S. Hooper,et al.  ROLE OF THE PHYSICOCHEMICAL ENVIRONMENT IN LUNG DEVELOPMENT , 2006, Clinical and experimental pharmacology & physiology.

[126]  Luciano Gattinoni,et al.  The concept of “baby lung” , 2005, Intensive Care Medicine.

[127]  J. Rychik,et al.  Fetal Cardiovascular Physiology , 2004, Pediatric Cardiology.

[128]  M. van de Bor,et al.  Recirculation in Double Lumen Catheter Veno-Venous Extracorporeal Membrane Oxygenation Measured by an Ultrasound Dilution Technique , 2001, ASAIO journal.

[129]  L. V. von Segesser,et al.  Nitric Oxide Added to the Sweep Gas Infusion Reduces Local Clotting Formation in Adult Blood Oxygenators , 2000, ASAIO journal.

[130]  S H Ridgway,et al.  Diving and swimming performance of white whales, Delphinapterus leucas: an assessment of plasma lactate and blood gas levels and respiratory rates. , 1997, The Journal of experimental biology.

[131]  M. Cereda,et al.  Acute Respiratory Failure, Mechanical Ventilation, and ECMO/ECCO2R: Quo Vadis? , 1997, The International journal of artificial organs.

[132]  M. Riccabona,et al.  Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. , 1996, The Journal of pediatrics.

[133]  N M Krivitski,et al.  Theory and validation of access flow measurement by dilution technique during hemodialysis. , 1995, Kidney international.

[134]  B. Lachmann,et al.  Open up the lung and keep the lung open , 1992, Intensive Care Medicine.

[135]  J. Y. Song,et al.  Immobilized carbonic anhydrase in a membrane lung for enhanced CO2 removal. , 1990, ASAIO transactions.

[136]  C. Saunier,et al.  Metabolic CO2 Removal by Dialysis: THAM vs NaOH Infusion , 1989, The International journal of artificial organs.

[137]  R. G. Cornell,et al.  National experience with extracorporeal membrane oxygenation for newborn respiratory failure. Data from 715 cases. , 1988, ASAIO transactions.

[138]  A. Pesenti,et al.  Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. , 1987, The American review of respiratory disease.

[139]  R. Fumagalli,et al.  Low-Frequency Positive-Pressure Ventilation with Extracorporeal CO2 Removal in Severe Acute Respiratory Failure , 1987 .

[140]  R. Fumagalli,et al.  Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. , 1986, JAMA.

[141]  B. Marshall,et al.  Influence of Mixed Venous Oxygen Tension (PVO2) on Blood Flow to Atelectatic Lung , 1983, Anesthesiology.

[142]  S. Garella,et al.  Complete Extracorporeal Removal of Metabolic Carbon Dioxide by Alkali Administration and Dialysis in Apnea , 1983, The International journal of artificial organs.

[143]  F. Cheney,et al.  Effects of Pulmonary Blood Flow and Mixed Venous O2 Tension on Gas Exchange in Dogs , 1983, Anesthesiology.

[144]  Rupert G. Miller,et al.  Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. , 1979, JAMA.

[145]  A. Pesenti,et al.  Clinical application of low frequency positive pressure ventilation with extracorporeal CO2 removal (LFPPV-ECCO2R) in treatment of adult respiratory distress syndrome (ARDS). , 1979, The International journal of artificial organs.

[146]  G. Iapichino,et al.  Hemodynamic, mechanical and renal effects during "apneic oxygenation" with extracorporeal carbon dioxide removal, at different levels of intrapulmonary pressure in lambs. , 1979, The International journal of artificial organs.

[147]  A. Pesenti,et al.  Extracorporeal carbon dioxide removal (ECCO2R): a new form of respiratory assistance. , 1979, The International journal of artificial organs.

[148]  L. Gattinoni,et al.  Control of intermittent positive pressure breathing (IPPB) by extracorporeal removal of carbon dioxide. , 1978, British journal of anaesthesia.

[149]  L. Gattinoni,et al.  Control of breathing using an extracorporeal membrane lung. , 1977, Anesthesiology.

[150]  R. Bartlett,et al.  Prolonged extracorporeal cardiopulmonary support in man. , 1974, The Journal of thoracic and cardiovascular surgery.

[151]  J. West,et al.  Proceedings: Instability of poorly ventilated lung units during oxygen breathing. , 1974, The Journal of physiology.

[152]  J J Osborn,et al.  Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. , 1972, The New England journal of medicine.

[153]  R. Kitz,et al.  Buying time with artificial lungs. , 1972, The New England journal of medicine.

[154]  A. E. Lawson,et al.  The effects of adrenaline and noradrenaline on venous return and regional blood flows in the anaesthetized cat with special reference to intestinal blood flow , 1966, The Journal of physiology.

[155]  J. Kennedy.  The role of assisted circulation in cardiac resuscitation. , 1966, JAMA.

[156]  E. Radford,et al.  VENTILATION AND OXYGEN REQUIREMENTS DURING PROLONGED ARTIFICIAL VENTILATION IN PATIENTS WITH RESPIRATORY FAILURE. , 1965, The New England journal of medicine.

[157]  M. B. Laver,et al.  IMPAIRED OXYGENATION IN SURGICAL PATIENTS DURING GENERAL ANESTHESIA WITH CONTROLLED VENTILATION. A CONCEPT OF ATELECTASIS. , 1963, The New England journal of medicine.

[158]  S T ANNING,et al.  THE HISTORICAL ASPECTS OF VENOUS THROMBOSIS , 1957, Medical History.

[159]  H. Lassen..  A preliminary report on the 1952 epidemic of poliomyelitis in Copenhagen with special reference to the treatment of acute respiratory insufficiency. , 1953, Lancet.

[160]  R. Riley,et al.  Ideal alveolar air and the analysis of ventilation-perfusion relationships in the lungs. , 1949, Journal of applied physiology.

[161]  D. Brodie,et al.  Mechanical Ventilation Management during ECMO for ARDS: An International Multicenter Prospective Cohort. , 2019, American journal of respiratory and critical care medicine.

[162]  F. Rapetti,et al.  Positive End-expiratory Pressure and Mechanical Power , 2019, Anesthesiology.

[163]  L. Bouadma,et al.  Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation , 2008, Intensive Care Medicine.

[164]  B. Marshall,et al.  A model for hypoxic constriction of the pulmonary circulation. , 1988, Journal of applied physiology.

[165]  A. Al-Jurf.  Positive end-expiratory pressure. , 1981, Surgery, gynecology & obstetrics.

[166]  L. Gattinoni,et al.  THE CARBON DIOXIDE MEMBRANE LUNG (CDML): A NEW CONCEPT , 1977, Transactions - American Society for Artificial Internal Organs.

[167]  R. Bartlett,et al.  Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. , 1979, Transactions - American Society for Artificial Internal Organs.